Pro­to­cols: In­fin­i­ty hunts up a buy­er for its dis­ap­point­ing can­cer drug du­velis­ib; Is North­west Bio fi­nal­ly broke?

Ab­b­Vie’s de­ci­sion to abrupt­ly pull out of its part­ner­ship with In­fin­i­ty on du­velis­ib large­ly wrecked the com­pa­ny’s hopes to fi­nal­ly make it big af­ter re­peat­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER